Tata India Pharma & Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank -
Rating
Growth Option 13-03-2026
NAV ₹29.07(R) -1.76% ₹34.14(D) -1.76%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 6.26% 23.39% 14.98% 18.6% 11.27%
Direct 7.89% 25.22% 16.71% 20.39% 13.03%
Nifty Pharma TRI 12.8% 26.24% 14.52% 14.92% 7.65%
SIP (XIRR) Regular -5.04% 10.62% 13.45% 16.49% 15.37%
Direct -3.6% 12.37% 15.19% 18.31% 17.13%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
1.09 0.56 0.92 -0.45% -0.39
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
16.14% -20.99% -16.36% 0.94 11.54%
Fund AUM As on: 30/12/2025 1326 Cr
Top Pharma Fund
Fund Name Rank Rating
Mirae Asset Healthcare Fund -

NAV Date: 13-03-2026

Scheme Name NAV Rupee Change Percent Change
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option 29.07
-0.5200
-1.7600%
TATA India Pharma & Healthcare Fund Regular Plan - Reinvestment of Income Distribution cum capital withdrawal option 29.07
-0.5200
-1.7600%
Tata India Pharma & Healthcare Fund-Regular Plan-Growth 29.07
-0.5200
-1.7600%
TATA India Pharma & Health Care Fund Direct Plan - Payout of Income Distribution cum capital withdrawal option 34.14
-0.6100
-1.7600%
TATA India Pharma & Healthcare Fund Direct Plan - Reinvestment of Income Distribution cum capital withdrawal option 34.14
-0.6100
-1.7600%
Tata India Pharma & Healthcare Fund-Direct Plan-Growth 34.14
-0.6100
-1.7600%

Review Date: 13-03-2026

Beginning of Analysis

The 4 star rating shows a very good past performance of the Tata India Pharma & Healthcare Fund in Pharma Fund. The Tata India Pharma & Healthcare Fund has a Jensen Alpha of -0.45% which is lower than the category average of 1.56%, showing poor performance. The Tata India Pharma & Healthcare Fund has a Sharpe Ratio of 1.09 which is lower than the category average of 1.19, showing poor performance.
The past performance of the {fund_name_eng} may or may not be sustained in the future. The review is not investment advice nor is it a recommendation to buy or sell funds.
Pharma Mutual Funds

Tata India Pharma & Healthcare Fund Return Analysis

The Tata India Pharma & Healthcare Fund has delivered a mixed performance across various time horizons, showcasing both strengths and challenges when compared to its Pharma Fund peers and the Nifty Pharma TRI benchmark. This analysis examines the fund’s returns over periods ranging from one month to ten years, alongside its Systematic Investment Plan (SIP) performance, highlighting its rankings within the Pharma Fund category and its ability to outperform or underperform the benchmark and category averages.

  • The fund has given a return of -1.23%, -4.16 and -5.23 in last one, three and six months respectively. In the same period the category average return was -0.15%, -2.19% and -3.48% respectively.
  • Tata India Pharma & Healthcare Fund has given a return of 7.89% in last one year. In the same period the Nifty Pharma TRI return was 12.8%. The fund has given 4.91% less return than the benchmark return.
  • The fund has given a return of 25.22% in last three years and rank 5th out of six funds in the category. In the same period the Nifty Pharma TRI return was 26.24%. The fund has given 1.02% less return than the benchmark return.
  • Tata India Pharma & Healthcare Fund has given a return of 16.71% in last five years and category average returns is 16.73% in same period. The fund ranked 3.0rd out of six funds in the category. In the same period the Nifty Pharma TRI return was 14.52%. The fund has given 2.19% more return than the benchmark return.
  • The fund has given a return of 13.03% in last ten years and ranked 2.0nd out of three funds in the category. In the same period the Nifty Pharma TRI return was 7.65%. The fund has given 5.38% more return than the benchmark return.
  • The fund has given a SIP return of -3.6% in last one year whereas category average SIP return is -0.42%. The fund one year return rank in the category is 8th in 12 funds
  • The fund has SIP return of 12.37% in last three years and ranks 5th in 5 funds. Mirae Asset Healthcare Fund has given the highest SIP return (15.98%) in the category in last three years.
  • The fund has SIP return of 15.19% in last five years whereas category average SIP return is 16.06%.

Tata India Pharma & Healthcare Fund Risk Analysis

  • The fund has a standard deviation of 16.14 and semi deviation of 11.54. The category average standard deviation is 15.51 and semi deviation is 10.99.
  • The fund has a Value at Risk (VaR) of -20.99 and a maximum drawdown of -16.36. The category average VaR is -18.18 and the maximum drawdown is -14.76. The fund has a beta of 0.93 which shows that fund is less volatile than the benchmark.

Standard deviation measures the fund's return volatility and Semi deviation focuses on downside volatility. Value at Risk (VaR) is a measure of the risk of investments. Maximum Drawdown is the maximum loss from a peak to a trough of a portfolio. Beta measures the volatility of the fund compared to the benchmark. A beta of 1 indicates that the fund will move in line with the benchmark. A beta of more than 1 indicates that the fund will be more volatile than the benchmark and vice versa.


  • Very Good Performance in Pharma Fund Category
  • Good Performance in Pharma Fund Category
  • Poor Performance in Pharma Fund Category
  • Very Poor Performance in Pharma Fund Category

    • Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

    Data Source: www.amfiindia.com

    SEBI Categorization


    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -1.33 2.94
    -0.25
    		-2.34 | 2.41 12 | 14 Average
    3M Return % -4.49 0.72
    -2.50
    		-5.86 | 0.84 11 | 14 Average
    6M Return % -5.91 3.11
    -4.13
    		-7.22 | -0.41 10 | 14 Average
    1Y Return % 6.26 12.80
    8.88
    		4.82 | 12.89 11 | 13 Average
    3Y Return % 23.39 26.24
    24.86
    		23.39 | 27.56 6 | 6 Average
    5Y Return % 14.98 14.52
    15.34
    		14.14 | 16.86 4 | 6 Good
    7Y Return % 18.60 14.92
    19.49
    		18.52 | 20.87 4 | 5 Good
    10Y Return % 11.27 7.65
    12.31
    		11.27 | 13.82 3 | 3 Average
    1Y SIP Return % -5.04
    -1.49
    		-6.58 | 4.05 9 | 13 Average
    3Y SIP Return % 10.62
    12.69
    		10.62 | 14.23 6 | 6 Average
    5Y SIP Return % 13.45
    14.56
    		13.45 | 16.51 6 | 6 Average
    7Y SIP Return % 16.49
    17.79
    		16.49 | 19.41 5 | 5 Average
    10Y SIP Return % 15.37
    15.82
    		15.37 | 16.55 3 | 3 Average
    Standard Deviation 16.14
    15.51
    		14.34 | 16.43 7 | 8 Poor
    Semi Deviation 11.54
    10.99
    		9.99 | 11.68 7 | 8 Poor
    Max Drawdown % -16.36
    -14.76
    		-16.36 | -12.33 8 | 8 Poor
    VaR 1 Y % -20.99
    -18.18
    		-21.68 | -15.67 7 | 8 Poor
    Average Drawdown % -4.59
    -5.42
    		-6.79 | -3.66 2 | 8 Very Good
    Sharpe Ratio 1.09
    1.19
    		1.08 | 1.37 7 | 8 Poor
    Sterling Ratio 0.92
    1.02
    		0.92 | 1.18 8 | 8 Poor
    Sortino Ratio 0.56
    0.63
    		0.56 | 0.72 8 | 8 Poor
    Jensen Alpha % -0.45
    1.56
    		-0.45 | 4.64 8 | 8 Poor
    Treynor Ratio -0.39
    -0.42
    		-0.47 | -0.39 3 | 8 Good
    Modigliani Square Measure % 24.74
    26.49
    		24.56 | 29.65 7 | 8 Poor
    Alpha % -2.22
    -1.30
    		-2.78 | 1.82 7 | 8 Poor
    Return data last Updated On : March 13, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
    KPIs: Key Performance Indicators

    Rotate the phone! Best viewed in landscape mode on mobile.
    KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
    1M Return % -1.23 2.94 -0.15 -2.22 | 2.53 12 | 14 Average
    3M Return % -4.16 0.72 -2.19 -5.70 | 1.19 12 | 14 Average
    6M Return % -5.23 3.11 -3.48 -6.75 | 0.40 10 | 14 Average
    1Y Return % 7.89 12.80 10.38 6.15 | 14.22 11 | 13 Average
    3Y Return % 25.22 26.24 26.32 24.88 | 28.62 5 | 6 Average
    5Y Return % 16.71 14.52 16.73 15.75 | 17.87 3 | 6 Good
    7Y Return % 20.39 14.92 20.91 19.72 | 22.39 3 | 5 Good
    10Y Return % 13.03 7.65 13.61 12.96 | 14.84 2 | 3 Good
    1Y SIP Return % -3.60 -0.42 -4.99 | 5.57 8 | 12 Average
    3Y SIP Return % 12.37 14.12 12.37 | 15.98 5 | 5 Average
    5Y SIP Return % 15.19 16.06 15.03 | 17.53 4 | 5 Good
    7Y SIP Return % 18.31 19.21 18.31 | 20.53 5 | 5 Average
    10Y SIP Return % 17.13 17.14 16.69 | 17.60 2 | 3 Good
    Standard Deviation 16.14 15.51 14.34 | 16.43 7 | 8 Poor
    Semi Deviation 11.54 10.99 9.99 | 11.68 7 | 8 Poor
    Max Drawdown % -16.36 -14.76 -16.36 | -12.33 8 | 8 Poor
    VaR 1 Y % -20.99 -18.18 -21.68 | -15.67 7 | 8 Poor
    Average Drawdown % -4.59 -5.42 -6.79 | -3.66 2 | 8 Very Good
    Sharpe Ratio 1.09 1.19 1.08 | 1.37 7 | 8 Poor
    Sterling Ratio 0.92 1.02 0.92 | 1.18 8 | 8 Poor
    Sortino Ratio 0.56 0.63 0.56 | 0.72 8 | 8 Poor
    Jensen Alpha % -0.45 1.56 -0.45 | 4.64 8 | 8 Poor
    Treynor Ratio -0.39 -0.42 -0.47 | -0.39 3 | 8 Good
    Modigliani Square Measure % 24.74 26.49 24.56 | 29.65 7 | 8 Poor
    Alpha % -2.22 -1.30 -2.78 | 1.82 7 | 8 Poor
    Return data last Updated On : March 13, 2026.
    Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Feb. 27, 2026
    KPIs: Key Performance Indicators

    Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


    Date Tata India Pharma & Healthcare Fund NAV Regular Growth Tata India Pharma & Healthcare Fund NAV Direct Growth
    13-03-2026 29.07 34.1358
    12-03-2026 29.5918 34.7472
    11-03-2026 29.8641 35.0656
    10-03-2026 29.8372 35.0327
    09-03-2026 29.5597 34.7054
    06-03-2026 29.7186 34.8879
    05-03-2026 29.7819 34.9609
    04-03-2026 29.6258 34.7762
    02-03-2026 29.9117 35.1092
    27-02-2026 30.0261 35.2393
    26-02-2026 30.2838 35.5404
    25-02-2026 30.0904 35.312
    24-02-2026 29.8547 35.0341
    23-02-2026 29.9839 35.1843
    20-02-2026 29.6748 34.8174
    19-02-2026 29.6951 34.8399
    18-02-2026 29.8642 35.0369
    17-02-2026 29.777 34.9333
    16-02-2026 29.6016 34.7262
    13-02-2026 29.4633 34.5599

    Fund Launch Date: 04/Dec/2015
    Fund Category: Pharma Fund
    Investment Objective: The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.
    Fund Description: A) Pharmaceuticals and Healthcare services sector oriented Fund b) Ideal for investors seeking focused investments in Health service and Medicine realated sectors
    Fund Benchmark: Nifty Pharma Total Return Index
    Source: Fund FactSheet

    Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.